Company Updates

Kazia’s Therapeutics Chief Executive Officer Dr James Garner was featured in a recent article in The Australian Financial Review on the new breed of biotechnology companies.

Zapaygo is currently offering up to USD $4,880,000 (£ 4,000,000) through the sale of up to 200 units to Accredited Investors. Each unit is USD $24,440 and consists of 166,667 security tokens.

Planet Ark Power’s smart voltage management system has featured in PV Magazine in regard to its capability to decrease grid instability caused by a surplus of solar energy.

Conveyancers, real estate agents, building inspectors, insurers and lenders will all collaborate on the app with buyers and sellers having access to track and manage the process in real-time.

Willowmore has been featured by GSMA as an innovator in 2019.

The recent decline in the domestic stocks is part of a global sell-off amidst recession fears in the US coupled with trade-war speculation along with all-in-all lacklustre economic forecasts.

Planet Ark Power feature in The Green List as a breakthrough solar power solution for commercial properties that is both viable, clean and free of voltage issues.

Kazia Therapeutics has announced that Memorial Sloan Kettering Cancer Center in New York will investigate the potential use of GDC-0084 for cancer that has spread to the brain.

Newground Capital Partners announces the repayment of a secured mezzanine facility.